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Infectious porcine circovirus type 2 (PCV2) was generated following transfection of a porcine retina cell line (VIDO R1) with
cloned circovirus DNA. Expression of open reading frame 2 (ORF2) was detected at 24 h postinfection and onwards
increasingly throughout the infection by Western blot analysis using ORF2 specific polyclonal antibody. Moreover, the ORF2
protein was also detected in purified PCV2 virus, indicating that ORF2 is a structural component of PCV2 viral capsid. Nuclear
localization of PCV2 ORF2 was demonstrated by immunofluorescence assay in PCV2-infected cells. An analysis of the
subcellular localization of a series of truncation mutants of ORF2 fused with the green fluorescent protein indicated that the
nuclear localization signal of ORF2 was conferred by the N-terminal 41 amino acids. This domain was further analyzed
through site-directed mutagenesis, suggesting that the presence of basic amino acid residues at positions 12 to 18 and 34
to 41 are important for the strict nuclear targeting of PCV2 ORF2. © 2001 Academic PressINTRODUCTION
As a member of the family Circoviridae, porcine circo-
virus (PCV) has a circular, single-stranded DNA genome
with a nonenveloped, icosahedral virus shell (Lukert et
al., 1995). PCV replicates in the cell nucleus and pro-
duces large intranuclear inclusion bodies (Murphy et al.,
1999). Currently, there are two recognized types of PCV.
PCV type 1 (PCV1) isolated as a persistent contaminant
of the continuous porcine kidney cell line PK-15 (ATCC
CCL31) does not cause detectable cytopathic effects in
cell culture and fails to produce clinical disease in pigs
after experimental infection (Allan et al., 1995; Tischer et
al., 1982, 1986). In contrast, PCV type 2 (PCV2) is closely
associated with postweaning multisystemic wasting syn-
drome (PMWS) in weanling pigs (Allen et al., 1998; Ellis
et al., 1998; Morozov et al., 1998). Comparison of the
nucleotide sequences of PCV1 (Mankertz et al., 1997;
Meehan et al., 1997) and PCV2 (Hamel et al., 1998;
Mankertz et al., 2000; Meehan et al., 1998) reveals ,80%
identity, although the genomic organization is similar,
especially in the arrangement of the two largest open
reading frames (ORFs) with a putative origin of DNA
replication. The largest ORF, ORF1, of the two types of
PCV shows only minor variation with a homology of 85%
and has been demonstrated to be the Rep protein in
PCV1 (Mankertz et al., 1998). A higher rate of variation
displayed in the ORF2 sequences of PCV1 and PCV2
(homology ;65%) would suggest that the type-specific
1 To whom reprint requests should be addressed at the Faculty of
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91features of PCV might be determined by the respective
ORF2 protein. In-line with this speculation, several PCV
type-specific epitopes have been mapped on ORF2 se-
quences by synthetic peptide scanning analysis (Mahe
et al., 2000). In another recent study, PCV2 ORF2
has been identified as a major structural protein
that can form viral capsid-like particles in insect cells
infected with ORF2-expressing recombinant baculovirus
(Nawagitgul et al., 2000).
Because of the potentially close relevance of PCV2
ORF2 to PCV2 pathogenicity, the characterization of
PCV2 ORF2 has become one of our research goals. To
this end, we have cloned PCV2 genome DNA isolated
from a piglet with PMWS (Liu et al., 2000). We have also
expressed the PCV2 ORF2 gene as a fusion protein in
Escherichia coli and generated a polyclonal antibody in
a rabbit (Liu et al., 2001). In this study we describe the
generation of infectious PCV2 virus upon transfection of
the cloned PCV2 genome DNA and the expression pro-
file of the ORF2 gene in PCV2-infected cells. We also
studied the intracellular localization of the PCV2 ORF2
protein. We found that PCV2 ORF2 encodes a nuclear
protein directed by the N-terminal domain (i.e., amino
acids 1 to 41). Site-directed mutagenesis experiments in
this domain assigned an important role of the individual
basic residues at positions 12 to 18 and 34 to 41 in the
complete nuclear localization of PCV2 ORF2.
RESULTS
Generation of the PCV2 virus by DNA transfection
In order to obtain a pure PCV2 virus preparation, we
transfected a molecularly cloned, double-stranded repli-
cative form of PCV2 genome DNA (Liu et al., 2000) into a
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92 LIU, TIKOO, AND BABIUKfetal porcine retina cell line transformed by the human
adenovirus-5 (HAV5) E1 gene (VIDO R1 cell line) (Reddy
et al., 1999). A previous study has shown that PCV1 can
replicate in several pig-derived cell cultures (Allan et al.,
1994), so we assumed that VIDO R1 cells would be
susceptible to PCV2 infection. Since the VIDO R1 cell line
was transformed by HAV5 E1 that can induce the S
phase of the cell cycle and transactivate transcription
(Shenk, 1996), we thought that it might also enhance
PCV2 replication. To test whether the VIDO R1 cell line
could be used to generate PCV2 virus, ;70% confluent
cells grown in a six-well dish was transfected by ;5 mg
of cloned PCV2 DNA. Prior to transfection, plasmid con-
taining full-length PCV2 genome was digested with SacII
and purified after agarose gel electrophoresis to remove
the vector portion. When the cells were confluent, they
were trypsinized and transferred to a T-25 flask. No CPE
was observed for 12 days posttransfection. Cells were
then harvested, frozen, thawed three times, and used to
infect fresh VIDO R1 cells. Polymerase chain reaction
(PCR) using DNA extracted from the infected cells as a
template and PCV2-specific primers amplified a product
FIG. 1. Characterization and titration of PCV2 virus generated by DNA
transfection. (A) PCR amplification of PCV2 viral DNA extracted from
infected VIDO R1 cells by Hirt’s method (1967). PCR using PCV2-
specific primers and DNA from PCV2-infected (lane 1) and mock-
infected (lane 2) cells. A plasmid containing the PCV2 genome was
used as a control (lane 3). The 1-kb DNA ladder (GIBCO BRL) was
loaded in lane M. (B) Titration of PCV2 by immunoperoxidase staining.
At 72 h.p.i., mock- (a) or PCV2- (b) infected VIDO R1 cells were incu-
bated with rabbit anti-ORF2 polyclonal antibody and biotinylated sec-
ondary antibody. After application of an avidin and biotinylated horse-
radish peroxidase complex, the monolayer was developed by DAB.
One dark cell/focus resulted from one virus particle infection.of the expected size, while no DNA was amplified from
the uninfected cells (Fig. 1A). Moreover, an immunohis-tochemical staining assay using anti-PCV2-ORF2 poly-
clonal antibody (Liu et al., 2001) showed a positive signal
only in PCV2-infected cells, while no staining was ob-
served in uninfected VIDO R1 cells (Fig. 1B). These data
indicated that we had obtained the PCV2 virus. The virus
was then expanded in cell culture and purified by ultra-
centrifugation. The immunostaining assay described
above was also used to determine the virus titer by
counting the positive-stained cells after serial dilutions of
the pelleted virus. The virus titer of this preparation was
calculated to be 2 3 107 infectious units (IU)/ml (Fig. 1B).
haracterization of PCV2 ORF2 expression in infected
ells
To analyze the expression of the ORF2 gene, VIDO R1
ells were infected with PCV2 virus at a multiplicity of
nfection (m.o.i.) of 1 and harvested at various hours
ostinfection (h.p.i.). Proteins in cell lysates were ana-
yzed by Western blot with anti-ORF2 polyclonal antibody
Liu et al., 2001). While no protein was observed in
ninfected cells, a 30-kDa protein band was detected in
CV2-infected cells as early as 24 h.p.i. and found to be
ccumulating to a greater amount at later time points
uring infection (Fig. 2). When the purified PCV2 virus
as analyzed in Western blot with the same anti-ORF2
ntibody, a similar band was also detected (Fig. 2). These
esults indicated that the PCV2 ORF2 gene was trans-
ated as a late protein that was incorporated into the
irus particles.
CV2 ORF2 localizes in the nucleus
To study the intracellular localization of PCV2 ORF2,
IDO R1 cells were seeded onto a two-well chamber
lide and infected with PCV2. At 48 h.p.i., indirect immu-
ofluorescence assay was carried out with anti-ORF2
ntibody. While no staining was visible in uninfected
IDO R1 cells, nuclear fluorescence was observed in
CV2-infected cells (Fig. 3), demonstrating that PCV2
RF2 was localized in the nucleus.
FIG. 2. Analysis of PCV2 ORF2 expression by Western blot using
anti-ORF2 antibody. VIDO R1 cells were either mock infected (lane 1) or
infected with PCV2 at a m.o.i. of 1 and harvested at 12 h (lane 2), 24 h
(lane 3), 36 h (lane 4), 48 h (lane 5), 60 h (lane 6), and 72 h (lane 7)
postinfection. Purified PCV2 virus was loaded in lane 8. The size of the
detected protein was indicated.
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93PCV2 ORF2 NUCLEAR LOCALIZATIONIntracellular localization of deletion mutants of PCV2-
ORF2-GFP fusion proteins
The nuclear targeting of a protein in eukaryotes is
frequently conferred by basic amino acid sequences.
PCV2 ORF2 contains a basic N-terminal region that may
have nuclear targeting activity (Fig. 4). To test this spec-
ulation, the wild-type and deletion mutants of PCV2 ORF2
were fused to the N-terminus of green fluorescent pro-
tein (GFP). Four C-terminal deletion mutants lacking 44,
139, 183, and 192 amino acids from the C-terminus of
ORF2, respectively, and one N-terminal mutant lacking 41
amino acids from the N-terminus of ORF2 were con-
structed (Fig. 5A). To examine the expression of the
proteins synthesized from the hybrid genes, Vero cells
were transfected with each plasmid under the control of
the CMV promoter. Equal aliquots of all lysates were
analyzed by Western blotting with anti-GFP antibody. As
shown in Fig. 5B, a fusion protein of the expected size
was produced from each expression plasmid.
Green fluorescence produced by the GFP portion in
each fusion protein was then used to analyze the intra-
cellular localization of these ORF2-GFP wild-type fusion
and truncation mutants in transfected Vero cells 20 h
after transfection. GFP expressed alone was distributed
almost equally throughout the cell (b in Fig. 5C), whereas
fusion of the wild-type ORF2 protein to GFP conferred
nuclear localization (c in Fig. 5C). These results indicated
that localization of the ORF2-GFP fusion protein was
directed by ORF2, not by the GFP moiety. Moreover,
nuclear localization of the ORF2-GFP fusion demon-
strated that the ORF2 protein can localize to the nucleus
without the assistance of other viral proteins.
The four mutants with progressive deletions from the
C-terminus of ORF2 also exhibited nuclear accumulation
(d–g in Fig. 5C), whereas the mutant with the N-terminal
41-amino-acid deletion localized almost exclusively in
the cytoplasm (h in Fig. 5C). These results indicated that
FIG. 3. Nuclear localization of PCV2 ORF2. At 48 h following mock (a)
r PCV2 (b) infection, VIDO R1 cells were fixed and permealized and
hen incubated with rabbit anti-ORF2 polyclonal antibody and FITC-
abeled anti-rabbit antibody. Cells were observed under a fluorescence
icroscope at a 4003 magnification.the nuclear targeting activity of PCV2 ORF2 was associ-
ated with the N-terminal 41 amino acid residues.Intracellular localization of the mutants in the ORF2
N-terminal nuclear targeting domain
In order to further characterize the contribution of the
basic amino acid residues in the N-terminal domain of
PCV2 ORF2, eight mutants were constructed with the
basic amino acid residues in this region substituted in
groups of three or two (Table 1). The expression of each
mutant PCV2 ORF2-GFP fusion protein in transfected
Vero cells was demonstrated by Western blot analysis
using anti-GFP antibody (Fig. 6A). The intracellular dis-
tribution of the eight mutants was determined after trans-
fection into Vero cells (Fig. 6B and Table 1). The R5S-
R6V-R7N, R9S-R10V-R11N, R24S-R25V-R26N, and H31S-
R33G mutants (Fig. 6B) were exclusively localized in the
nuclei of transfected cells, similar to the wild-type PCV2
ORF2-GFP (Fig. 5C), indicating that these basic residues
are not required for the nuclear targeting of PCV2 ORF2.
In contrast, the mutations of the basic residues in posi-
tions 12 to 14, 16 to 18, 34 to 37, and 39 to 41 in the
N-terminal domain resulted in a diffuse distribution of
both nuclear and cytoplasmic fluorescence (Fig. 6B),
indicating that the basic residues at these positions are
required for the complete nuclear localization of PCV2
ORF2.
DISCUSSION
The goal of this study was to investigate the expres-
sion and intracellular localization of the PCV2 ORF2 pro-
tein. First of all, we attempted to establish a pure PCV2
virus in cell culture. In two earlier published papers,
PCV2 virus was obtained from PCV-free porcine kidney
(PK-15) cells after transfection with a cloned PCV2 ge-
nome (Meehan et al., 1998; Mahe et al., 2000). In both
cases the porcine kidney cells were treated with D-
lucosamine, as it can stimulate entry to the S phase in
he cell cycle in PK-15 cells (Tischer et al., 1987). It should
FIG. 4. Amino acid sequence of PCV2 ORF2. The single-letter amino
acid code is used and the residues are shown in groups of ten. The
sequence of the N-terminal domain is in bold letters with the residues
important for the nuclear localization of PCV2 ORF2 underlined. Also
shown are consensus patterns present in the PCV2 ORF2 sequence for
potential posttranslational modifications indicated by symbols above
the respective residues. h, N-myristoylation; , protein kinase phos-
phorylation site; {, casein kinase phosphorylation site; , N-glycosyl-
ation site.
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95PCV2 ORF2 NUCLEAR LOCALIZATIONbe noted, however, that D-glucosamine is toxic for cell
culture, so the treatment must be performed with caution
and hence should be avoided whenever possible (Allan
and Ellis, 2000). In this report, a fetal porcine retina cell
line (VIDO R1) was transfected with a cloned PCV2 ge-
nome and infectious PCV2 virus was also generated. In
contrast to the porcine kidney cell line, we found that
D-glucosamine treatment of VIDO R1 cells was not nec-
essary, presumably because the VIDO R1 cell line has
been transformed by HAV5 E1, which can induce the S
phase in the cell cycle.
As a first report, we also developed a quantitative
assay to titrate PCV2 virus based on immunohistochem-
ical (IHC) staining of infected cells using anti-ORF2 an-
tibody. Previous studies on PCV1 titration used an indi-
rect immunofluorescence assay (IFA) and counted the
number of fluorescing cells (Tischer et al., 1986, 1995).
For a comparative purpose, the PCV2 virus preparation
was also titrated by IFA and the result was the same as
that obtained by IHC, indicating that the two assays have
similar sensitivities. However, besides that the IHC stain-
ing lasts much longer than IFA, the stained monolayer
dishes in IHC could be easily labeled and thus divided
into small viewing areas under a light microscope, ren-
dering the counting of the positive cells very easy to
perform, as opposed to the IFA method.
The generated PCV2 virus was then used to study the
expression of the ORF2 gene. In PCV2-infected cells, a
30-kDa protein was detected in Western blots using
anti-ORF2 antibody, consistent with a recent study
FIG. 5. PCV2 ORF2 contains an N-terminal nuclear targeting domai
truncation constructs. The expected molecular mass and the subcellu
Western blotting analysis, using anti-GFP monoclonal antibody, of th
harvested 20 h after transfection. GFP (lane 3), wild-type PCV2 ORF2-G
C) (lane 7), 192 (C) (lane 8), and 41 (N) (lane 9) were expressed. T
) were also loaded as controls. The positions of molecular sizes mar
T
Overview of Site-Directe
PCV2 ORF2-GFP genotype Amino aci
Wild type MTYPRRRYRRRRH
R5S-R6V-R7N MTYPSVNYRRRRH
R9S-R10V-R11N MTYPRRRYSVNRH
R12S-H13V-R14N MTYPRRRYRRRSVN
R16V-H18A MTYPRRRYRRRRH
R24S-R25V-R26N MTYPRRRYRRRRH
H31S-R33G MTYPRRRYRRRRH
H34V-R35N-R37V MTYPRRRYRRRRH
R39S-R40V-K41N MTYPRRRYRRRRH
Note. The intracellular localizations of the resulting PCV2 ORF2-GFP
a The eight double or triple amino acid mutations underlined were clasmids expressing GFP (b), fusion proteins PCV2 ORF2-GFP (c), ORF2-
192(C)-GFP (g), and ORF2-41(N)-GFP (h) were photographed 20 h after tra(Nawagitgul et al., 2000). In a previous report, we showed
that in vitro translation of the PCV2 ORF2 gene also
yielded a 30-kDa protein (Liu et al., 2001), suggesting that
the ORF2 protein is not posttranslationally modified in
virus-infected cells, although PCV2 ORF2 contains sev-
eral consensus patterns (Fig. 4). The temporal regulation
of PCV2 ORF2 gene expression in PCV2-infected cells
indicated that ORF2 is probably a late protein because
the expression was detected only after 24 h.p.i. and the
amount increased at later time points in viral infection.
Moreover, ORF2 was also detected in purified virus,
suggesting that ORF2 probably takes part in the late
events of the virus replication cycle, e.g., the assembly of
the progeny viruses as a structural component.
Using anti-ORF2 antibody, PCV2 ORF2 was character-
ized to be a nuclear protein in virus-infected cells by
immunofluorescence assay. Figure 3 is the nuclear fluo-
rescence of ORF2 at 48 h.p.i. We also have data showing
the nuclear fluorescence of PCV2 ORF2 at 24 and
72 h.p.i., suggesting that there is no change in the intra-
cellular localization of ORF2 in the PCV2 replication cy-
cle.
Many nuclear targeting sequences have been identi-
fied. Even though there does not exist a strict consensus
nuclear localization signal (NLS), stretches of basic
amino acids are the principal components of NLS se-
quences (Silver, 1991), which are generally classified as
one of three types (reviewed in Boulikas, 1993; Hicks and
Raikhel, 1995; Nakai and Kanehisa, 1992). The “pat4”
motif consists of a continuous stretch of four basic amino
chematic representation of the wild-type PCV2 ORF2-GFP fusion and
lization of each fusion are indicated to the right of each plasmid. (B)
-GFP protein and its deletion mutants expressed in Vero cells and
e 4), and its deletion mutants 44 (C) (lane 5), 139 (C) (lane 6), 183
tes of mock-transfected (lane 1) and pTargeT vector-transfected (lane
e shown to the left. (C) Vero cells transfected by pTargeT vector (a) or
agenesis Experimentsa
ence (positions 1 to 41) Localization
LGQILRRRPWLVHPRHRYRWRRK N
LGQILRRRPWLVHPRHRYRWRRK N
LGQILRRRPWLVHPRHRYRWRRK N
LGQILRRRPWLVHPRHRYRWRRK N 1 C
GQILRRRPWLVHPRHRYRWRRK N 1 C
LGQILSVNPWLVHPRHRYRWRRK N
LGQILRRRPWLVSPGHRYRWRRK N
LGQILRRRPWLVHPRVNVRWRRK N 1 C
LGQILRRRPWLVHPRHRYRWSVN N 1 C
products are indicated (N, nuclear; C, cytosolic).
out on the N-terminal domain of PCV2 ORF2.n. (A) S
lar loca
e ORF2
FP (lan
he lysa
kers arABLE 1
d Mut
d sequ
RPRSH
RPRSH
RPRSH
PRSH
RPVSAL
RPRSH
RPRSH
RPRSH
RPRSH44(C)-GFP (d), ORF2-139(C)-GFP (e), ORF2-183(C)-GFP (f), ORF2-
nsfection at a 4003 magnification.
nutant; h
96 LIU, TIKOO, AND BABIUKacids or three basic amino acids with histidine or proline.
The pat7 motif begins with proline and is followed within
three residues by a segment containing three basic res-
idues of four. The third type of NLS, the “bipartite” motif,
consists of two basic amino acids, a 10-amino-acid
spacer and a 5-amino-acid segment containing at least
three basic residues. The actual functioning of a partic-
ular NLS sequence in nuclear localization of a protein
requires several additional factors, such as whether the
motif is exposed on the surface of the molecule.
In search of the NLS within PCV2 ORF2, we have
identified two amino acid stretches that represent the
nuclear targeting sequence. This experiment began with
the evaluation of the intracellular localization of ORF2-
GFP constructs expressing truncations of the ORF2
gene. When the first 41 amino acids of the PCV2 ORF2
FIG. 6. Intracellular localization of mutants in the nuclear targeting do
proteins by Western blot using anti-GFP monoclonal antibody. Lanes:
R9S-R10V-R11N mutant; 5, R12S-H13V-R14N mutant; 6, R16V-H18A mu
mutant; 10, R39S-R40V-K41N mutant. The size of the detected protein
proteins after transfection into Vero cells. a, R5S-R6V-R7N mutant; b, R
R24S-R25V-R26N mutant; f, H31S-R33G mutant; g, H34V-R35N-R37V mwere deleted, the resulting mutant PCV2 ORF2-GFP fu-
sion protein became cytoplasmic, in contrast to the spe-cific nuclear localization of the wild-type PCV2 ORF2-
GFP. We also demonstrated that this 41-amino-acid do-
main was sufficient to target GFP to the nucleus when
linked to the 59-end of the GFP gene. The site-directed
mutagenesis studies performed in the nuclear targeting
domain revealed that the mutant proteins with replace-
ment of the arginine and histidine residues in two
stretches consisting of seven and eight amino acids
(12R-H-R-P-R-S-H18 and 34H-R-Y-R-W-R-R-K41), respectively,
lost the strict nuclear localization, as observed in the
case of the wild-type PCV2 ORF2-GFP fusion protein. The
first nuclear targeting stretch overlaps a pat4 motif (11R-
R-H-R14) and also represents part of the N-terminal por-
tion of a bipartite motif (11R-R-H-R-P-R-S-H-L-G-Q-I-L-R-R-
R-P27), while the second stretch comprises the C-termi-
al portion of another bipartite sequence (25R-R-P-W-L-V-
41
f PCV2 ORF2. (A) Analysis of expression of the mutant PCV2 ORF2-GFP
geT vector; 2, wild-type PCV2 ORF2-GFP; 3, R5S-R6V-R7N mutant; 4,
R24S-R25V-R26N mutant; 8, H31S-R33G mutant; 9, H34V-R35N-R37V
ndicated. (B) Intracellular localization of the mutant PCV2 ORF2-GFP
0V-R11N mutant; c, R12S-H13V-R14N mutant; d, R16V-H18A mutant; e,
, R39S-R40V-K41N mutant.main o
1, pTar
tant; 7,
was i
9S-R1H-P-R-H-R-Y-R-W-R-R-K ). In contrast, mutations of the
basic amino acids within the other two pat4 motifs and
97PCV2 ORF2 NUCLEAR LOCALIZATIONone pat7 sequence present in the PCV2 ORF2 did not
affect nuclear signaling.
In conclusion, we have shown that PCV2 virus could
be generated by DNA transfection of VIDO R1 cells. We
have also described the expression of PCV2 ORF2 as a
late protein and a structural component of the virus
particles. Finally, we have shown that the N-terminal 41
amino acids of PCV2 ORF2 were necessary and suffi-
cient for its specific nuclear localization. Detailed analy-
sis of the N-terminal domain by site-directed mutagene-
sis revealed two amino acid stretches 12R-H-R-P-R-S-H18
and 34H-R-Y-R-W-R-R-K41, as being essential for the strict
nuclear targeting of PCV2 ORF2.
MATERIALS AND METHODS
Cell culture
Fetal porcine retina cell line (VIDO R1) (Reddy et al.,
1999) and Vero cells were maintained at 37°C with 5%
CO2 in Eagles-based MEM media supplemented with 10
or 5% heat-inactivated fetal bovine serum (FBS), respec-
tively.
Transfection and infection
Monolayers of VIDO R1 cells grown in a six-well dish
were transfected with cloned PCV2 DNA using Lipofectin
according to the manufacturer’s recommendations
(GIBCO BRL). Prior to transfection, the PCV2 full-length
genome was released from the plasmid by digestion with
SacII (Liu et al., 2000). For infection, the transfected VIDO
R1 cells were subjected to three cycles of freezing
(270°C) and thawing (37°C). The lysate was then clari-
fied by centrifugation and used to infect fresh VIDO R1
cells.
For transient expression, analysis of GFP-containing
fusion proteins, Vero cells in six-well dishes, or chamber
slides were transfected by Lipofectamine and Plus re-
agent (GIBCO BRL). The intracellular localization of each
fusion protein was observed 20 h after transfection with
the aid of a fluorescein isothiocyanate (FITC) filter-
equipped fluorescence microscope (Olympus AH-2).
Virus purification and titration after
immunohistochemical staining
For purification of the PCV2 virus, PCV2-infected VIDO
R1 cells were incubated with 0.5% Triton X-114 in phos-
phate-buffered saline (PBS) at 37°C for 45 min followed
by Freon 113 (1,1,2-trichlorotrifluoroethane) extraction.
The cell debris and membranes were clarified by cen-
trifugation at 2000 g for 15 min. The viruses in the su-
pernatant were pelleted at 35000 g for 3 h through a 20%
sucrose cushion. The virus pellet was suspended in PBS
and stored at 270°C. Virus titers were determined as
infectious units by quantitative ORF2 protein immunoper-
oxidase staining. For this purpose, the cell monolayers in12-well dishes were infected with serial dilutions of virus.
After adsorption of virus for 1 h at 37°C, the cells were
washed and overlaid with MEM containing 2% FBS and
0.7% agarose. On day 3 postinfection, the agarose over-
lay was removed and the cells were fixed and perme-
abilized with methanol/acetone (1:1 in volume) for 20 min
at 220°C. After blocking with 1% bovine serum albumin
for 1 h at room temperature, the cells were incubated
with rabbit anti-ORF2 serum (Liu et al., 2001). After 2 h
incubation, the plates were washed with PBS and then
processed using the VECTASTAIN Elite ABC kit (Vector
Laboratories). The reaction was developed with 3,39-
diaminobenzidine (DAB) tetrahydrochloride and ob-
served under a microscope. By counting the positively
stained cells, the virus titer was expressed as IU, where
1 IU was defined as one positively stained cell/focus at
3 days p.i.
Viral DNA extraction and characterization
Viral DNA was extracted from PCV2-infected VIDO R1
cell monolayers by the method of Hirt (1967). The viral
DNA was then analyzed by PCR as described earlier (Liu
et al., 2000).
Plasmid constructions
Molecular cloning was performed by standard tech-
niques (Sambrook et al., 1989).
Construction of the full-length PCV2 genome clone.
The cloning of the PCV2 genome was described previ-
ously (Liu et al., 2000). The double-stranded replicative
form of the full-length PCV2 genome DNA can be re-
leased from the resulting plasmid upon SacII digestion.
Construction of PCV2-ORF2-GFP wild-type fusion and
deletion mutants. Plasmid constructs are schematically
shown in Fig. 5A. The vectors used in the construction
were pQBI25 [containing a GFP coding sequence under
the control of a cytomegalovirus (CMV) immediate early
promoter; Quantum Biotechnologies] and pTargeT (con-
taining a CMV immediate early promoter; Promega). The
NheI-PstI (753 bp) fragment containing the GFP gene
from pQBI25 was ligated to a NheI-PstI-digested PCR
product (template, PCV2 full-length clone; primers, 59-
AAT TCT GCA GAT GAA TAA TAA AAA CCA TTA CGA
A-39 and 59-AAT TCT GCA GAA TTC GCT AGC GGG TTC
AAG TGG GGG GTC-39). The ORF2-GFP fusion gene was
then amplified by PCR from the resulting plasmid using
primers 59-GGG GGG GGA TCC CGT TTT CAG CTA TGA
CGT ATC-39 and 59-TCC CAG CTG TAG AAG CTC TC-39,
and the BamHI-digested fragment (1440 bp) was inserted
into pTargeT vector, creating pORF2-GFP (Fig. 5A). Ex-
pression plasmids encoding the fusion of GFP with a
series of deletion mutants of PCV2 ORF2 were generated
from the pORF2-GFP plasmid by PCR primer-mediated
mutagenesis. For this purpose, the coding sequences for
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98 LIU, TIKOO, AND BABIUKthe N-terminal 41, 50, 94, and 189 as well as the C-
terminal 192 amino acid residues were amplified by PCR
and substituted for the full-length ORF2 in pORF2-GFP
via appropriate restriction enzymes. The PCR fragments
were confirmed by DNA sequencing.
Site-directed mutagenesis of the basic amino acid
residues in the N-terminal domain. Eight double or triple
amino acid substitutions in the N-terminal region of
PCV2 ORF2 gene were constructed either by primer-
directed PCR fragment mutagenesis or through insertion
of pairs of complementary oligonucleotides between two
restriction sites (Table 1). Synthetic oligonucleotides
used were designed to mutate all the basic amino acid
residues in the N-terminal domain as follows: for the
R5S-R6V-R7N mutation, forward primer 59-CAAGC
GTTAA CTACC GCAGA AGAAG ACAC-39 and backward
rimer 59-GGCGG TGTCT TCTTC TGCGG TAGTT AACG-
9; for the R9S-R10V-R11N mutation, forward primer
-CAAGG AGGCG TTACA GCGTT AACAG ACAC-39 and
ackward primer 59-GGCGG TGTCT GTTAA CGCTG
AACG CCTC-39; for the R12S-H13V-R14N mutation, for-
ard primer 59-CAAGG AGGCG TTACC GCAGA AGAAG
GTTA ACCCC CGCAG CCATC TTGG-39 and backward
rimer 59-CCAAG ATGGC TGCGG GGGTT AACGC
TCTT CTGCG GTAAC GCCTC-39; for the R16V-H18A
utation, forward primer 59-CGCCC CGTGA GCGCT
TTGG-39 and backward primer 59-CCAAG AGCGC
CACG G-39; for the R24S-R25V-R26N mutation, forward
rimer 59-GGGGG GGTTA ACCCC TGGCT CGTCC
CCC-39 and backward primer 59-GGGGG GGTTA
CGCT GAGGA TCTGG CCAAG ATGG-39; for the H31S-
33G mutation, forward primer 59-GGGGG GCCCG
GCAC CGCTA CCGTT GGAGA A-39 and backward
rimer 59-GGGGG GCCCG GGGCT GACGA GCCAG
GGCG GC-39; for the H34V-R35N-R37V mutation, for-
ard primer 59-GGGGG GTACG TATGG AGAAG GAAAA
TGGC ATC-39 and backward primer 59-GGGGG GTACG
AGTT AACGC GGGGG TGGAC GAGCC-39; for the R39S-
40V-K41N mutation, forward primer 59-GGGGG GGTTA
CAAT GGCAT CTTCA ACACC CG-39 and backward
rimer 59-GGGGG GGTTA ACGCT CCAAC GGTAG
GGTG GCG-39. Mutant clones were identified by re-
triction analysis and DNA sequencing.
estern blot analysis
Proteins in cell lysates were separated by SDS–PAGE
n 10% gels using a discontinuous buffer system
Laemmli, 1970). Western blotting was carried out using
nti-ORF2 polyclonal (1:200) (Liu et al., 2001) or anti-GFP
onoclonal (1:500, Clontech) antibodies and peroxidase-
abeled anti-species antibodies (1:5000, Kirkegaard &
erry Laboratories). The blots were developed with
-chloro-1-naphthol (Bio-Rad).ndirect immunofluorescence assay
Cells were grown in a two-well chamber slide and
nfected with PCV2 at a multiplicity of infection of 1. At
8 h.p.i., cells were washed with PBS before they were
ixed and permeabilized with methanol/acetone (1:1 in
olume) for 20 min at 220°C. The cells were blocked for
onspecific reactivity by incubation with 1% bovine se-
um albumin in PBS for 1 h. The cells were incubated
ith rabbit anti-ORF2 antibody (1:500 in PBS) for 2 h
ollowed by a 1-h reaction with FITC-conjugated anti-
abbit IgG (1:500 in PBS, Jackson ImmunoResearch Lab-
ratories Inc.). Cells were observed and photographed
ith a fluorescence microscope at a 4003 magnification.
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